title: American Academy of Allergy, Asthma and Immunology (AAAAI)-2010 annual meeting. 26 February-2 March 2010, New Orleans, LA, USA.
abstract: The 2010 American Academy of Allergy, Asthma and Immunology (AAAAI) meeting, held in New Orleans, included topics covering new therapeutic developments in the fields of allergy, asthma and immunological diseases. This conference report highlights selected presentations on potential treatments for food and other allergies, as well as therapies for asthma and other immunological diseases. Investigational drugs discussed include Oralair Mites (Stallergenes SA/Paladin Labs Inc), PF-03654746 (Pfizer Inc) and AMG-853 (Amgen Inc).
authors.affiliation: Rutgers University, Center for Environmental Prediction, 14 College Farm Road, New Brunswick, NJ 08901-8551, USA. bielory@envsci.rutgers.edu
authors.forename: Leonard
authors.initials: L
authors.lastname: Bielory
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D015507:Drugs, Investigational / Q000494:pharmacology* / Q000627:therapeutic use; D005512:Food Hypersensitivity / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000276:immunology; D007154:Immune System Diseases / Q000188:drug therapy* / Q000276:immunology
chemical_list: D015507:Drugs, Investigational